What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Platelet-derived growth factor receptor, Cell biology, Growth factor, Platelet-derived growth factor and Signal transduction.
The various areas that Carl-Henrik Heldin examines in his Platelet-derived growth factor receptor study include Molecular biology, Cancer research, Autophosphorylation and Cell culture.
His work carried out in the field of Cell biology brings together such families of science as Transforming growth factor, beta 3, Biochemistry, Cell type and Chemotaxis.
His Growth factor research includes themes of Progenitor cell, Endocrinology and Autocrine signalling.
His Platelet-derived growth factor research is multidisciplinary, incorporating elements of Epidermal growth factor, Gene expression, In situ hybridization, Immunology and Glioma.
Carl-Henrik Heldin has researched Signal transduction in several fields, including Bone morphogenetic protein, Phosphorylation and Ectopic expression.
His most cited work include:
- TGF-beta signalling from cell membrane to nucleus through SMAD proteins (3313 citations)
- Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor (1996 citations)
- Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling (1568 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Cell biology, Platelet-derived growth factor receptor, Platelet-derived growth factor, Receptor and Growth factor.
Cell biology is a component of his Signal transduction, SMAD, Transforming growth factor, Phosphorylation and Transforming growth factor beta studies.
His SMAD research includes elements of R-SMAD, Transcription factor and Bone morphogenetic protein.
His Platelet-derived growth factor receptor research is multidisciplinary, incorporating perspectives in Molecular biology, Cancer research, Receptor tyrosine kinase and Endocrinology.
Paracrine signalling is closely connected to Autocrine signalling in his research, which is encompassed under the umbrella topic of Platelet-derived growth factor.
His Growth factor research incorporates themes from Cell culture, Epidermal growth factor, Cell growth, Chemotaxis and Platelet.
He most often published in these fields:
- Cell biology (47.04%)
- Platelet-derived growth factor receptor (45.35%)
- Platelet-derived growth factor (26.90%)
What were the highlights of his more recent work (between 2010-2021)?
- Cell biology (47.04%)
- Cancer research (19.80%)
- Transforming growth factor (17.09%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Cell biology, Cancer research, Transforming growth factor, Signal transduction and Platelet-derived growth factor receptor.
His Cell biology study combines topics in areas such as Receptor and Ubiquitin ligase.
His work deals with themes such as Cancer cell, Transcription factor, Autocrine signalling and Liver X receptor, which intersect with Transforming growth factor.
His study in Signal transduction is interdisciplinary in nature, drawing from both Cell surface receptor, Tissue homeostasis and Protein kinase A.
A large part of his Platelet-derived growth factor receptor studies is devoted to Platelet-derived growth factor.
His research in Transforming growth factor beta intersects with topics in TGF beta signaling pathway and Molecular biology.
Between 2010 and 2021, his most popular works were:
- Regulation of EMT by TGFβ in cancer. (324 citations)
- Targeting the PDGF signaling pathway in tumor treatment (284 citations)
- Signaling Receptors for TGF-β Family Members (232 citations)
In his most recent research, the most cited papers focused on:
Carl-Henrik Heldin focuses on Cancer research, Signal transduction, Cell biology, Transforming growth factor and Receptor.
His studies deal with areas such as Cell migration, Immunology, Cytokine, Tumor progression and Transforming growth factor beta as well as Cancer research.
His Signal transduction research focuses on Phosphorylation and how it connects with SUMO protein.
The concepts of his Cell biology study are interwoven with issues in Embryonic stem cell, Epidermal growth factor, Cellular differentiation, Internalization and Ubiquitin ligase.
His work in Platelet-derived growth factor receptor, Cell surface receptor and Growth factor receptor is related to Receptor.
Carl-Henrik Heldin studies Platelet-derived growth factor which is a part of Platelet-derived growth factor receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
